Relationship of c-erbB-2 expression to clinicopathological features and prognosis in gastric cancer

被引:0
|
作者
Karayiannakis, AJ [1 ]
Syrigos, KN [1 ]
Chatzigianni, E [1 ]
Valinos, P [1 ]
Bousiakos, P [1 ]
Balas, G [1 ]
Lakiotis, G [1 ]
Simatos, G [1 ]
机构
[1] IKA Hosp 1, Dept Surg 1, Athens, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, the expression of c-erbB-2 was investigated immunohistochemically in 61 formalin-fixed, paraffin-embedded specimens of gastric carcinoma. Membranous c-erbB-2 immunoreactivity was observed in 36% of tumours. Intestinal type tumours had a significantly higher incidence of c-erbB-2 expression than did diffuse type tumours. c-erbB-2 expression correlated with serosal invasion, lymph node metastasis and advanced tumour stage compared with c-erbB-2 negative tumours. Survival rates of patients with c-erbB-2 positive carcinomas were significantly lower than those with c-erbB-2 negative carcinomas. These findings suggest that erbB-2 expression is associated with an aggressive phenotype and poor prognosis in gastric cancer.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 50 条
  • [11] c-erbB-2 protein expression and clinicopathologic features in colorectal cancer
    Ishida, H
    Sadahiro, S
    Suzuki, T
    Ishikawa, K
    Tajima, T
    Makuuchi, H
    ONCOLOGY REPORTS, 2000, 7 (06) : 1229 - 1233
  • [12] THE RELATIONSHIP BETWEEN C-ERBB-2 EXPRESSION, S-PHASE FRACTION AND PROGNOSIS IN BREAST-CANCER
    OREILLY, SM
    BARNES, DM
    CAMPLEJOHN, RS
    BARTKOVA, J
    GREGORY, WM
    RICHARDS, MA
    BRITISH JOURNAL OF CANCER, 1991, 63 (03) : 444 - 446
  • [13] Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis
    Ferrero-Poüs, M
    Hacène, K
    Bouchet, C
    Le Doussal, V
    Tubiana-Hulin, M
    Spyratos, F
    CLINICAL CANCER RESEARCH, 2000, 6 (12) : 4745 - 4754
  • [14] RELATIONSHIP OF C-ERBB-2 PROTEIN EXPRESSION AND GENE AMPLIFICATION TO INVASION AND METASTASIS IN HUMAN GASTRIC-CANCER
    MIZUTANI, T
    ONDA, M
    TOKUNAGA, A
    YAMANAKA, N
    SUGISAKI, Y
    CANCER, 1993, 72 (07) : 2083 - 2088
  • [15] C-ERBB-2 EXPRESSION IN PRIMARY GASTRIC CARCINOMAS AND THEIR METASTASES
    DAVID, L
    SERUCA, R
    NESLAND, JM
    SOARES, P
    SANSONETTY, F
    HOLM, R
    BORRESEN, AL
    SOBRINHOSIMOES, M
    MODERN PATHOLOGY, 1992, 5 (04) : 384 - 390
  • [16] Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer
    Shpitz, B
    Bomstein, Y
    Sternberg, A
    Klein, E
    Liverant, S
    Groisman, G
    Bernheim, J
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (04) : 252 - 257
  • [17] c-erbB-2 expression in primary breast cancer
    Tagliabue, E
    Ménard, S
    Robertson, JFR
    Harris, L
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (01): : 16 - 26
  • [18] Expression of MIF and c-erbB-2 in endometrial cancer
    Xiao, Wei
    Dong, Xiujuan
    Zhao, Honghui
    Han, Shiyu
    Nie, Ruixue
    Zhang, Xiahua
    An, Ruifang
    MOLECULAR MEDICINE REPORTS, 2016, 13 (05) : 3828 - 3834
  • [19] Evaluation of histological features and expression of c-erbB-2 oncoprotein in cervical cancer grades
    Butler, D
    Kay, EW
    Walsh, CB
    Leader, M
    BRITISH JOURNAL OF CANCER, 1998, 78 : 65 - 65
  • [20] Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis
    Liduan Zheng
    Mixia Weng
    Meng Qi
    Teng Qi
    Ling Tong
    Xiaohua Hou
    Qiangsong Tong
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 163 - 172